Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Global Credit Crisis Said To Open Doors For Malaysian Biotechs

This article was originally published in PharmAsia News

Executive Summary

The current worldwide economic crisis puts Malaysian startup biotechnology companies in a good position to seek mergers and acquisitions to expand their business abroad. CEO Datuk Iskandar Mizal Mahmood of Malaysian Biotechnology said Malaysia's organization of biotechs, BioNexus, can help raise funds to buy foreign biotechs. They would be firms facing problems with obtaining credit, particularly those in the United States and Europe. He said many of those foreign companies already are seeking collaborations. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts